MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-12-2026
DexCom Operating Expenses 2011-2026 | DXCM
Annual Operating Expenses DexCom
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.89 B | 1.84 B | 1.69 B | 1.49 B | 1.41 B | 981 M | 789 M | 850 M | 535 M | 442 M | 336 M | 198 M | 129 M | 102 M | 80.7 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.89 B | 80.7 M | 851 M |
Quarterly Operating Expenses DexCom
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 476 M | 455 M | - | 442 M | 469 M | 461 M | - | 418 M | 418 M | 415 M | - | 347 M | 372 M | 357 M | - | 329 M | 316 M | 298 M | - | 246 M | 216 M | 223 M | 208 M | 191 M | 207 M | 183 M | 387 M | 155 M | 158 M | 150 M | 142 M | 128 M | 131 M | 134 M | 123 M | 120 M | 106 M | 94.3 M | 89.6 M | 117 M | 69.6 M | 59.2 M | 57.8 M | 52.2 M | 45.7 M | 42.1 M | 36.4 M | 33.4 M | 31.8 M | 27.4 M | 25.9 M | 25.7 M | 25.9 M | 24.8 M | 22.9 M | 21.5 M | 19.3 M | 17 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 476 M | 17 M | 183 M |
Operating Expenses of other stocks in the Diagnostics research industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
58 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Bioventus
BVS
|
217 M | $ 9.19 | 2.06 % | $ 612 M |  USA |
|
Biodesix
BDSX
|
106 M | $ 15.31 | 4.22 % | $ 1.99 B | USA |
|
Akumin
AKU
|
778 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Enzo Biochem
ENZ
|
47.4 M | - | -8.98 % | $ 14.8 K | USA |
 |
Check-Cap Ltd.
CHEK
|
14.1 M | - | - | $ 9.42 M |  Israel |
 |
Oxford Immunotec Global PLC
OXFD
|
59.4 M | - | - | $ 562 M |  Britain |
 |
Lantheus Holdings
LNTH
|
123 M | $ 74.11 | -2.15 % | $ 5 B | USA |
 |
DermTech
DMTK
|
104 M | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
37.1 M | - | -6.19 % | $ 10.5 M | USA |
 |
Co-Diagnostics
CODX
|
45.3 M | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Accelerate Diagnostics
AXDX
|
77.2 M | - | -61.36 % | $ 2.46 M | USA |
 |
Medpace Holdings
MEDP
|
118 M | $ 463.46 | 1.43 % | $ 13.4 B | USA |
 |
Global Cord Blood Corporation
CO
|
451 M | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
134 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
5.91 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
983 M | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
585 M | - | - | $ 10.7 B | USA |
 |
Charles River Laboratories International
CRL
|
607 M | $ 159.84 | 1.16 % | $ 7.92 B | USA |
 |
IQVIA Holdings
IQV
|
2.94 B | $ 165.65 | -0.81 % | $ 28.5 B | USA |
 |
Myriad Genetics
MYGN
|
964 M | $ 4.67 | 0.11 % | $ 432 M | USA |
 |
Biocept
BIOC
|
21.6 M | - | -13.05 % | $ 7.29 M | USA |
 |
National Research Corporation
NRC
|
38.5 M | $ 17.26 | -1.46 % | $ 386 M | USA |
 |
Invitae Corporation
NVTA
|
343 M | - | - | $ 21.2 M | USA |
 |
BioNano Genomics
BNGO
|
41.3 M | $ 1.22 | -16.44 % | $ 6.64 M | USA |
 |
Mettler-Toledo International
MTD
|
1.01 B | $ 1 261.71 | 1.72 % | $ 26 B |  Schweiz |
 |
Interpace Biosciences
IDXG
|
21.8 M | $ 1.71 | 0.73 % | $ 7.5 M | USA |
 |
Illumina
ILMN
|
3.69 B | $ 125.17 | 1.11 % | $ 19.9 B | USA |
 |
Pacific Biosciences of California
PACB
|
600 M | $ 1.38 | -1.08 % | $ 414 M | USA |
 |
QIAGEN N.V.
QGEN
|
821 M | - | - | $ 10.6 B |  Niderland |
 |
Precipio
PRPO
|
13.6 M | $ 27.01 | 0.3 % | $ 35.1 M | USA |
 |
Celcuity
CELC
|
113 M | $ 101.12 | -5.27 % | $ 3.99 B | USA |
 |
Personalis
PSNL
|
44.5 M | $ 7.67 | 0.72 % | $ 454 M | USA |
 |
Chembio Diagnostics
CEMI
|
28.5 M | - | 0.22 % | $ 16.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.87 B | $ 266.56 | 0.81 % | $ 22.2 B | USA |
 |
Motus GI Holdings
MOTS
|
18.6 M | - | -34.28 % | $ 263 K | Israel |
 |
RadNet
RDNT
|
1.98 B | $ 59.22 | -4.09 % | $ 4.45 B | USA |
 |
ENDRA Life Sciences
NDRA
|
10.8 M | $ 3.49 | 0.29 % | $ 1.87 M | USA |
 |
NeoGenomics
NEO
|
430 M | $ 7.87 | -2.82 % | $ 1.01 B | USA |
 |
Natera
NTRA
|
258 M | $ 193.75 | -3.17 % | $ 19.1 B | USA |
 |
Senseonics Holdings
SENS
|
61.8 M | $ 6.63 | 0.08 % | $ 277 M | USA |
 |
Sotera Health Company
SHC
|
309 M | $ 13.82 | -0.43 % | $ 3.92 B | USA |
 |
CareDx, Inc
CDNA
|
411 M | $ 17.65 | 0.51 % | $ 941 M | USA |
 |
Soleno Therapeutics
SLNO
|
181 M | $ 30.84 | -2.77 % | $ 1.57 B | USA |
 |
OPKO Health
OPK
|
217 M | $ 1.14 | -1.3 % | $ 791 M | USA |
 |
Castle Biosciences
CSTL
|
59.5 M | $ 25.23 | -2.02 % | $ 701 M | USA |
 |
DarioHealth Corp.
DRIO
|
49.3 M | $ 8.05 | 7.27 % | $ 32.1 M | Israel |
 |
Neuronetics
STIM
|
104 M | $ 1.47 | -8.12 % | $ 96.9 M | USA |
 |
Exact Sciences Corporation
EXAS
|
2.47 B | $ 104.91 | - | $ 19.8 B | USA |